Skip to NavigationSkip to content

News

The decision marks a reversal of NICE’s original decision to reject the drug due to concerns over its cost-effectiveness, now that AstraZeneca has...
Novartis and Roche have been fined €444 million in France for abusive practices the companies implemented to push Lucentis over a cheaper drug.
The ruling is particularly disappointing for patients as there is currently no NHS-approved maintenance treatment in this indication, with treatment...
The opioids that these companies sold included tramadol and oxycodone, which have significant risks of addiction and misuse and have led to overdose...
The top 10 news stories this week largely cover COVID-19 vaccines, as hundreds of thousands of people in China have been inoculated with two...
The FDA has approved a new indication of Trelegy Ellipta for the treatment of asthma and patients with chronic obstructive pulmonary disease.
Pascal Soriot, Chief Executive of AstraZeneca, said that the company’s vaccine could still be available this year, despite the clinical trials being...
Pfizer-BioNTech announced Wednesday that preliminary preclinical data from mouse and macaque monkey models showed a strong immune response from its...
President Trump knew how much more deadly coronavirus was than the flu, despite public comments saying that the threat of the virus was overblown....
The coronavirus news this week focuses on lockdowns and infections, as England is set to increase lockdown restrictions across the country after a...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches